Acme is a leading provider of Oral Solid and Sterile Dosage form Contract Manufacturing and Development services to the pharmaceutical industry. Acme began its journey in 2005 and in a decade has transformed into a trusted partner and a complete solution provider, having expanded into niche segments of Oral Hormones both Sex Hormones and Levothyroxine along with General Injectables both Liquids and Lyophilized, catering through three state of the art manufacturing facilities. Today it employs more than 1500 highly- skilled workforce in its facilities which are located in Northern India, the facilities are spread over an area of approx 500,000 sq ft having a capacity of 15 Billion Tablets, 5 Billion Capsules and 42 Million Ampoules / Vials. In our journey over the past decade we have been audited and approved by various international regulatory agencies like USFDA, UKMHRA, EU-GMP- Hungary, ANVISA, PICS-Ukraine, INVIMA, WHO-Geneva, Phillippines, Vietnam, TFDA, Nepal, NAFDACNigeria, Niger, NDA Uganda, FDA Ghana, PPB Kenya, DDA Nepal, DDF Cambodia, Senegal, Sierra Leone, US FDA filing planned for Q1, 2018 and UL for 21CFR Parts 210 & 211 as we continue our journey towards building a sustainable future we have audits lined by US FDA* in 2018